A new platinum(II) complex containing a pyridine nucleus and a dithiocarbamate moiety as ligands ([Pt(ESDT)(Py)Cl]) was evaluated for in vitro cytotoxicity in the cisplatin-sensitive human ovarian 2008 and in the isogenic-resistant C13* cell lines. In both cell types, a tumor cell growth inhibition greater than cisplatin and a complete lack of cross-resistance in C13* cells were found. Despite its molecular size, [Pt(ESDT)(Py)Cl] accumulation was much higher than cisplatin both in parent and resistant cells. Studying the mechanism of action in cell-free media, we established that [Pt(ESDT)(Py)Cl] more efficiently interacts with DNA in vitro compared to cisplatin maintaining a binding preference for GG rich sequences of DNA. On the contrary, DNA platination in vivo by [Pt(ESDT)(Py)Cl] was found lower than cisplatin. An analysis of the type of DNA lesions induced by [Pt(ESDT)(Py)Cl] suggests that the cytotoxic efficacy and the ability to overcome cisplatin resistance seem to be related to a different mechanism of interaction with DNA and/or with other key cellular components.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0009-2797(02)00037-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impacts of amino acid-linked platinum(II) complexes on DNA structure.
J Biol Inorg Chem
January 2025
Department of Chemistry, Wayne State University, Detroit, MI, USA.
The discovery of cisplatin (cisPt) as an effective anticancer agent was a milestone in the health industry. Despite its success, undesired side effects and acquired resistance still limit the therapeutic usefulness of cisPt. Intrastrand adduct formation at consecutive purines and structural modifications of DNA caused by platinum(II) complexes are important factors for antitumor efficacy.
View Article and Find Full Text PDFReversible Piezochromism of Platinum(II) and Palladium(II) Dimers in Molecular Single Crystals.
Nano Lett
January 2025
Institute of Physics, Center for Nanotechnology (CeNTech), University of Münster, 48149 Münster, Germany.
Transition metal complexes are well-known for their efficient light emission and are promising for applications ranging from bioimaging to light-emitting diodes. In solution, interactions between the metal centers of two complexes become possible and drastically change the photophysical properties. For real-world devices, solid-state materials consisting of these molecules are preferable.
View Article and Find Full Text PDFRecent advances in ruthenium (III) complex-loaded nanomaterial for enhanced cancer therapy efficacy.
Drug Dev Ind Pharm
January 2025
Guangxi Key Laboratory of Drug Discovery and Optimization, School of Pharmacy, Guilin Medical University, Guilin, China.
Objective: Amid the escalating global cancer incidence, the development of effective and safe anticancer drugs is a critical priority in medical research. Addressing the clinical shortcomings of ruthenium-based anticancer drugs are currently a prominent focus of research.
Significance And Methods: Since the pioneering work with platinum derivatives, significant progress has been made in the fundamental studies of metal complexes for the treatment of a wide range of cancers, and there has been a growing interest in their properties and biomedical applications.
Carbazolylpyridine ()-based tetradentate platinum(II) complexes containing fused 6/5/6 metallocycles.
Dalton Trans
January 2025
College of Chemical Engineering, State Key Laboratory Breeding Base of Green-Chemical Synthesis Technology, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, P. R. China.
A series of carbazolylpyridine ()-based 6/5/6 Pt(II) complexes featuring tetradentate ligands with nitrogen or oxygen atoms as bridging groups was designed and synthesized, and the bridging nitrogen atoms were derived from acridinyl (Ac), azaaceridine (AAc) and carbazole (Cz). Systematic experimental and theoretical studies reveal that the ligand structures have a significant effect on the electrochemical, photophysical and excited state properties of these complexes. Their oxidation processes mainly occur on the carbazole-Pt moieties, whereas the reduction processes typically occur on the electron-deficient pyridine (Py) moieties.
View Article and Find Full Text PDFCorrection: A novel platinum(II) complex with a berberine derivative as a potential antitumor agent targeting G-quadruplex DNA.
Org Biomol Chem
January 2025
College of Marine Sciences, Beibu Gulf University, Qinzhou, China.
Correction for 'A novel platinum(II) complex with a berberine derivative as a potential antitumor agent targeting G-quadruplex DNA' by Shu-Lin Zhang , , 2025, https://doi.org/10.1039/d4ob01705f.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!